scholarly journals The Central Sensitization Inventory validated and adapted for a Brazilian population: psychometric properties and its relationship with brain-derived neurotrophic factor

2017 ◽  
Vol Volume 10 ◽  
pp. 2109-2122 ◽  
Author(s):  
Wolnei Caumo ◽  
Luciana Antunes ◽  
Jéssica Lorenzzi Elkfury ◽  
Evelyn Herbstrith ◽  
Raquel Busanello Sipmann ◽  
...  
2019 ◽  
Vol Volume 12 ◽  
pp. 2487-2502 ◽  
Author(s):  
José Ary Berniger Romariz ◽  
Cássio Nonnemacher ◽  
Mylena Abreu ◽  
Joice Dickel Segabinazi ◽  
Janete Shatkoski Bandeira ◽  
...  

2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Michel Klute ◽  
Marjan Laekeman ◽  
Katrin Kuss ◽  
Frank Petzke ◽  
Angela Dieterich ◽  
...  

Abstract Background The Central Sensitization Inventory (CSI) is a screening tool designed to detect symptoms related to Central Sensitization (CS) and Central Sensitivity Syndromes (CSS) by measuring the degree of related phenomena. The objective of this study was to create a German, culturally-adapted version of the CSI and to test its psychometric properties. Methods A German version of the CSI (CSI-GE) was developed, culturally-adapted, and pretested for comprehensibility. The psychometric properties of the resulting version were validated in a clinical study with chronic pain and pain-free control subjects. To assess retest reliability, the CSI-GE was administered twice to a subgroup of patients. Structural validity was tested using factor analyses. To investigate construct validity a hypotheses testing approach was used, including (1) correlations between the CSI-GE and several other well-established questionnaires as well as (2) an investigation of the CSI-GE discriminative power between different subgroups of participants believed to have different degrees of CS. Results The CSI-GE showed excellent reliability, including high test-retest characteristics. Factor analyses confirmed a bi-factor dimensionality as has been determined previously. Analysing construct validity 6 out of 11 hypotheses (55%) were met. CSI-GE scores differentiated between subgroups according to expectations. Correlations between CSI-GE scores and other questionnaires suggested that none of the correlated constructs was identical, but there was overlap with other questionnaires based on symptom load. Several correlations did not fit with our current understanding of CS. Conclusion The CSI-GE appears to be a reliable tool for measuring CS/CSS-related symptomatology. Whether this implies that the CSI-GE measures the degree of CS within an individual subject remains unknown. The resulting score should be interpreted cautiously until further clarification of the construct.


Pain Practice ◽  
2020 ◽  
Vol 20 (2) ◽  
pp. 188-196 ◽  
Author(s):  
Paraskevi Bilika ◽  
Randy Neblett ◽  
George Georgoudis ◽  
Zacharias Dimitriadis ◽  
Emmanouil Fandridis ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document